- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Bladder and Urothelial Cancer Treatments
- Cardiac Arrhythmias and Treatments
- Urinary and Genital Oncology Studies
- Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Cancer-related molecular mechanisms research
- Appendicitis Diagnosis and Management
- Lung Cancer Diagnosis and Treatment
- Metabolism, Diabetes, and Cancer
- Esophageal and GI Pathology
- Cardiac electrophysiology and arrhythmias
- Pneumothorax, Barotrauma, Emphysema
- Cancer, Lipids, and Metabolism
- Abdominal Surgery and Complications
- Atrial Fibrillation Management and Outcomes
- Cancer, Hypoxia, and Metabolism
Peking University
2022-2025
Peking University Cancer Hospital
2022-2025
First Affiliated Hospital of Soochow University
2023-2024
Soochow University
2023-2024
Tongji Hospital
2024
Huazhong University of Science and Technology
2024
•The CMISG1701 trial assessed the safety and efficacy of nCRT versus nCT followed by MIE for locally advanced bulky ESCC.•The strategy could not improve survival significantly compared with strategy.•The best neoadjuvant therapy ESCC remains a pending issue. BackgroundNeoadjuvant is recommended esophageal cancer, but optimal unclear. We aimed to evaluate chemoradiotherapy (nCRT) chemotherapy (nCT) minimally invasive esophagectomy (MIE) squamous cell carcinoma (ESCC).Patients methodsEligible...
The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which providing important information on baseline characteristics, treatment patterns, and 1-year outcomes patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian recruited this registry. A total of 52,014 AF were enrolled globally; these, 1388 26 sites within India (2012–2016). In India, mean age was 65.8...
The advantages of en bloc resection bladder tumors (ERBT) over transurethral (TURBT) in terms patient prognosis are not yet clear, and there some technical limitations. We aimed to compare the tumor recurrence non-muscle invasive cancer (NMIBC) patients with diameter ≥ 3 cm undergoing either TURBT or thulium laser ERBT.
To investigate the application value of tumor abnormal protein in patients with type 2 diabetes mellitus complicated lung adenocarcinoma
The increasing number of type 2 diabetes mellitus (T2DM) patients leads to higher rates morbidity and mortality related lung cancer. To investigate the utility proliferating cell nuclear antigen Ki-67 in with adenocarcinoma situ (AIS) complicated by T2DM. One hundred AIS T2DM (group A), 100 alone B), 60 benign lesions C) admitted Department Thoracic Surgery Endocrinology First Affiliated Hospital Soochow University from November 2021 December 2022 were enrolled. expression was compared among...